Deploying Medical Imaging AI Across Hospital Sites: The Distribution Shift Problem CTOs Are Underestimating

Most teams moving from a single-site pilot to a multi-site rollout treat accuracy as the primary deployment risk. They benchmark the model on held-out data from the training site, hit a number that satisfies clinical stakeholders, and then discover, sometimes months into production, that performance at the second or third site is materially worse. The degradation is rarely dramatic enough to trigger an alert. It accumulates quietly, in edge cases and borderline predictions, until someone starts auditing outputs manually. The underlying cause is almost always the same: the model learned the imaging characteristics of one scanner, one protocol, one patient population, and those characteristics do not transfer cleanly to a different hospital environment.

Companion piece to our broader work on cross-site medical AI generalization. See Cross-Modality Medical Imaging AI for Healthcare for a wider treatment of domain adaptation trade-offs and generalization risks in clinical imaging deployments.

Why Scanner Heterogeneity Is an Architectural Problem, Not a Data Problem

The instinct when encountering cross-site performance degradation is to ask for more data. The reasoning is intuitive: if the model has not seen Site B's scanner, train it on Site B's data. This framing is not wrong, but it is incomplete, and in clinical settings it is often operationally impractical.

Annotation in medical imaging is expensive and slow. A segmentation mask for a brain MRI volume requires expert radiologist time that most health systems cannot spare at scale. Collecting enough labeled data from every new site to retrain or fine-tune a model creates a deployment bottleneck that compounds with every site added to the network.

The more productive framing is to ask whether the model architecture itself is capable of generalizing across domains without requiring proportional increases in labeled data. That is an architectural question, not a data pipeline question, and it has concrete implications for which models you evaluate and how you structure your validation regime.

What Distribution Shift Actually Looks Like in Brain MRI

Distribution shift in medical imaging is not a single phenomenon. It manifests across several distinct axes that interact in ways that are difficult to disentangle after the fact.

Scanner and Protocol Variation

Different MRI manufacturers and field strengths produce images with different contrast profiles, noise characteristics, and spatial resolution. A model trained on 3T Siemens data will encounter different voxel-level statistics when deployed against 1.5T GE acquisitions. The model has not seen these statistics during training, so its internal representations, calibrated to the training distribution, produce outputs that are systematically miscalibrated on the new inputs.

Patient Population Shift

Beyond hardware, the patient population at Site B may differ in ways that affect image characteristics. Age distributions, comorbidities, and disease prevalence all influence what the model encounters in production. A model trained on a relatively homogeneous academic medical center cohort may have learned shortcuts that do not hold when deployed in a community hospital serving a different demographic.

Annotation Protocol Differences

If a model is eventually retrained using annotations from multiple sites, differences in how radiologists at each site delineate structures introduce label noise that conventional training procedures do not handle well. This is a less-discussed source of shift, but it affects any federated or multi-site fine-tuning strategy.

The Case for Parameter-Efficient Architectures Under Annotation Scarcity

Recent research on Implicit Neural Representations in brain MRI segmentation surfaces a finding that is directly relevant to multi-site deployment decisions. Shang et al. (arXiv 2026) found that INR-based segmentation models do not improve monotonically with parameter count. Their advantage over conventional architectures like U-Net is most pronounced in low-parameter regimes and under limited augmentation conditions. U-Net-based models benefit more from larger parameter budgets and standard augmentation pipelines.

This matters for multi-site deployment because the conditions that favor INR-based approaches are precisely the conditions that characterize new site onboarding: limited labeled data, constrained compute for fine-tuning, and a distribution that differs from the training environment.

The practical implication is that model selection for a multi-site rollout should not be based solely on single-site benchmark accuracy. A model that achieves the highest Dice score on your training site under full-data conditions may be the wrong choice for a deployment where you are routinely adapting to new sites with small annotation budgets.

HierINRSeg and the Principle of Multi-Layer Representation

The architectural insight that Shang et al. (arXiv 2026) translate into their HierINRSeg model is worth understanding at a mechanistic level, because it points toward a general principle rather than a specific implementation detail.

Standard INR-based segmentation reads semantic information from a single layer of the network. The research shows that segmentation-relevant structure is distributed across multiple INR layers, and that aggregating these representations hierarchically produces models that generalize better out-of-domain. HierINRSeg achieves an average improvement of 8.2 percentage points in Dice on out-of-domain test sets compared to the MetaSeg baseline, against 5.6 percentage points in-domain.

The gap between in-domain and out-of-domain improvement is the operationally significant number here. A model that improves more on out-of-domain data than on in-domain data is, by definition, a model whose gains are concentrated in the generalization problem. For a CTO evaluating architectures for a multi-site rollout, that asymmetry is more informative than absolute benchmark scores.

Validation Infrastructure for Multi-Site Deployments

Choosing an architecture that is better suited to cross-domain generalization is necessary but not sufficient. The validation regime has to be designed to surface distribution shift before it becomes a production problem.

Single-site holdout evaluation will not catch scanner-specific degradation. The validation set needs to include data from held-out sites, not just held-out patients from the training site. This requires establishing data sharing agreements and annotation protocols with partner sites before model training begins, not after.

Monitoring in production needs to track performance proxies at the site level, not just aggregate metrics. If Site C's model outputs begin drifting from radiologist corrections at a rate that differs from Sites A and B, that is a signal that the model has encountered a distribution it was not prepared for. Aggregate accuracy metrics will mask this until the gap is large enough to be clinically visible.

The infrastructure decisions that determine whether a model trained at one site works at another are made before the first line of training code is written. They live in how you structure your validation data, how you instrument production monitoring, and which architectural trade-offs you accept when annotation budgets are constrained.